全文获取类型
收费全文 | 1984篇 |
免费 | 84篇 |
国内免费 | 14篇 |
专业分类
耳鼻咽喉 | 48篇 |
儿科学 | 21篇 |
妇产科学 | 15篇 |
基础医学 | 223篇 |
口腔科学 | 31篇 |
临床医学 | 130篇 |
内科学 | 641篇 |
皮肤病学 | 102篇 |
神经病学 | 178篇 |
特种医学 | 42篇 |
外国民族医学 | 25篇 |
外科学 | 165篇 |
综合类 | 3篇 |
一般理论 | 1篇 |
预防医学 | 189篇 |
眼科学 | 6篇 |
药学 | 115篇 |
中国医学 | 9篇 |
肿瘤学 | 138篇 |
出版年
2023年 | 12篇 |
2022年 | 26篇 |
2021年 | 52篇 |
2020年 | 43篇 |
2019年 | 62篇 |
2018年 | 61篇 |
2017年 | 28篇 |
2016年 | 43篇 |
2015年 | 34篇 |
2014年 | 77篇 |
2013年 | 122篇 |
2012年 | 129篇 |
2011年 | 175篇 |
2010年 | 87篇 |
2009年 | 75篇 |
2008年 | 131篇 |
2007年 | 126篇 |
2006年 | 122篇 |
2005年 | 116篇 |
2004年 | 103篇 |
2003年 | 99篇 |
2002年 | 80篇 |
2001年 | 26篇 |
2000年 | 26篇 |
1999年 | 24篇 |
1998年 | 13篇 |
1997年 | 14篇 |
1996年 | 15篇 |
1995年 | 8篇 |
1994年 | 8篇 |
1993年 | 4篇 |
1992年 | 14篇 |
1991年 | 13篇 |
1990年 | 6篇 |
1989年 | 6篇 |
1988年 | 9篇 |
1987年 | 7篇 |
1986年 | 8篇 |
1985年 | 11篇 |
1984年 | 13篇 |
1983年 | 7篇 |
1982年 | 8篇 |
1981年 | 4篇 |
1979年 | 6篇 |
1978年 | 4篇 |
1972年 | 3篇 |
1971年 | 4篇 |
1970年 | 2篇 |
1968年 | 3篇 |
1967年 | 2篇 |
排序方式: 共有2082条查询结果,搜索用时 15 毫秒
101.
102.
103.
Diane Pourchot M.D. Christine Bodemer M.D. Ph.D. Alice Phan M.D. Ph.D. Anne‐Claire Bursztejn M.D. Ph.D. Smaïl Hadj‐Rabia M.D. Ph.D. Franck Boralevi M.D. Ph.D. Juliette Miquel M.D. Thomas Hubiche M.D. Eve Puzenat M.D. Anne‐Laure Souillet M.D. Ingrid Kupfer M.D. Maryam Piram M.D. Alain Beauchet M.D. Emmanuel Mahé M.D. Groupe de Recherche de la Société Française de Dermatologie Pédiatrique 《Pediatric dermatology》2017,34(1):58-63
104.
L.A. Soria P.M. Corva A. Branda Sica E.L. Villarreal L.M. Melucci C.A. Mezzadra J. Papaleo Mazzucco G. Fernndez Macedo C. Silvestro A. Schor M.C. Miquel 《Molecular and cellular probes》2009,23(6):304-308
The PPARGC1A gene (peroxysome proliferator-activated receptor-γ coactivator 1α gene) controls muscle fiber type and brown adipocyte differentiation; therefore, it is a candidate gene for beef quality traits (tenderness and fat content). Two SNPs (Single Nucleotide Polymorphisms) were identified within exon 8 by multiple alignment of DNA sequences obtained from 24 bulls: a transition G/A (SNP 1181) and a transversion A/T (SNP 1299). The SNP 1181 is a novel SNP, corresponding to a non-conservative substitution (AGT/AAT) that could be the cause of amino acid substitution (364Serine/364Asparagine). A Mismatch PCR method was designed to determine genotypes of 73 bulls and 268 steers for SNP 1181. Growth, slaughter and meat quality information were available for the group of steers. Allele A of SNP 1181 was not found in Angus. In 243 steers, no significant differences (P > 0.05) were found for either final live body weight, gain in backfat thickness in Spring, kidney fat weight, kidney fat percentage, Warner–Bratzler shear force at 7 days postmortem, intramuscular fat percentage or meat colour between genotype GG and AG. This SNP could be included in breed composition and population admixture analyses because there are marked differences in allelic frequencies between Bos taurus and Bos indicus breeds. 相似文献
105.
A student, future decision-maker, has to measure the consequences of his indecision. In this study, a model of work with doubt is tested. We observe that the indecision is correlate with knowledge. His taking into consideration from continuous assessments allows us to predict his academic standard. 相似文献
106.
M Julia García-Fuster Marcelino Ferrer-Alcón Miquel Martín Brigitte L Kieffer Rafael Maldonado Jesús A García-Sevilla 《European neuropsychopharmacology》2007,17(5):366-374
The acute effects of opiate drugs and opiate addiction have been associated with modulation of Fas/FADD (Fas-Associated protein with Death Domain) signaling complex in the rat brain. This study investigated the possible existence of endogenous opioid tones regulating the basal activities of Fas receptor forms and FADD in the brain, using gene-targeted mice lacking mu-, delta- or kappa-opioid peptide receptors (KO mice). In mu-KO mice, but not in delta- or kappa-KO mice, the basal immunodensity of native Fas (35 kDa monomeric form) was decreased in the cerebral cortex (33%) when compared with WT littermates. In delta-KO mice, but not in mu- or kappa-KO mice, the basal content of 120 kDa Fas aggregates (complexes of monomers relevant in Fas signaling) was markedly increased in the cortex (93%). In contrast, no differences between genotypes were observed in the basal expression of glycosylated Fas (51/48/45 kDa forms). Notably, the basal content of FADD (the adaptor protein that couples Fas to caspases and transmits the death signal) was increased in the cerebral cortex of delta-KO mice (48%), but not in mu- or kappa-KO mice. In addition, the basal content of phosphorylated FADD at Ser191 (the relevant species of FADD implicated in nonapoptotic signals) was also upregulated in the cortices of delta-opioid receptor KO mice (6.5-11.0-fold). The results suggest that mu-receptors tonically stimulate (through endogenous opioid peptides) the activation of native Fas, whereas delta-receptors tonically inhibit the expression of Fas aggregates and that of FADD and phosphorylated FADD (Ser191) in the mouse brain. These data are in line with the acute opposite modulation of Fas and FADD induced by mu- and delta-opiate agonists, and strongly support the notion of an anti-apoptotic delta-opioid tone that restrains Fas signaling. 相似文献
107.
108.
109.
Noninvasive ventilation during persistent weaning failure: a randomized controlled trial 总被引:18,自引:0,他引:18
Ferrer M Esquinas A Arancibia F Bauer TT Gonzalez G Carrillo A Rodriguez-Roisin R Torres A 《American journal of respiratory and critical care medicine》2003,168(1):70-76
To assess the efficacy of noninvasive ventilation (NIV) in patients with persistent weaning failure, we conducted a prospective, randomized, controlled trial in 43 mechanically ventilated patients who had failed a weaning trial for 3 consecutive days. This trial was stopped after a planned interim analysis. Patients were randomly extubated, receiving NIV (n = 21), or remained intubated following a conventional-weaning approach consisting of daily weaning attempts (n = 22). Compared with the conventional-weaning group, the noninvasive-ventilation group had shorter periods of invasive ventilation (through tracheal intubation) (9.5 +/- 8.3 vs. 20.1 +/- 13.1 days, p = 0.003) and intensive care unit (ICU) (14.1 +/- 9.2 vs. 25.0 +/- 12.5 days, p = 0.002) and hospital stays (27.8 +/- 14.6 vs. 40.8 +/- 21.4 days, p = 0.026), less need for tracheotomy to withdraw ventilation (1, 5% vs. 13, 59%, p < 0.001), lower incidence of nosocomial pneumonia (5, 24% vs. 13, 59%, p = 0.042) and septic shock (2, 10% vs. 9, 41%, p = 0.045), and increased ICU (19, 90% vs. 13, 59%, p = 0.045) and 90-day survival (p = 0.044). The conventional-weaning approach was an independent risk factor of decreased ICU (odds ratio: 6.6; p = 0.035) and 90-day survival (odds ratio: 3.5; p = 0.018). Earlier extubation with NIV results in shorter mechanical ventilation and length of stay, less need for tracheotomy, lower incidence of complications, and improved survival in these patients. 相似文献
110.
Andreu H Rimola A Bruguera M Navasa M Cirera I Grande L García-Valdecasas JC Rodés J 《Transplantation》2002,73(12):1936-1943
BACKGROUND: Predictive factors of response to antirejection therapy in acute cellular rejection (ACR) in liver transplantation are not well established. METHODS: To investigate the possible existence of these factors, we reviewed 111 consecutive episodes of ACR fulfilling the following criteria: histologically confirmed ACR; cyclosporine-based immunosuppression; initial antirejection treatment with high-dose steroid boluses; minimum follow-up of 2 weeks after treatment; and no other graft complication interfering with evaluation of therapeutic response. ACR episodes not responding to initial steroid therapy were given additional treatment (OKT3 and/or repeated steroid boluses). We analyzed the association of the response to the antirejection treatment with different clinical, laboratory, histological, and donor-recipient compatibility variables at two times: after the initial antirejection therapy, and after all the antirejection therapy administered. RESULTS: Eighty episodes of ACR (72%) resolved after the initial therapy with high-dose steroid boluses, and another 18 (16%), initially steroid-resistant, resolved with additional antirejection treatment. Thirteen episodes (12%) were refractory to all antirejection treatment administered. Variables with independent predictive value of nonresponse to initial therapy with steroid boluses were late-onset ACR (>2 months after transplantation), high serum bilirubin and alanine aminotransferase, low blood cyclosporine concentration in the week before antirejection treatment, and severe histological endothelialitis. Late-onset ACR and high serum bilirubin were also independent predictors of refractoriness to all the treatment administered. CONCLUSIONS: Response to antirejection treatment in ACR in liver transplantation can be predicted by several clinical and laboratory data. ACR episodes with factors predictive of therapeutic unresponsiveness could benefit from more aggressive antirejection treatment. 相似文献